Development and Validation of a Diagnostic Nomogram for Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Pneumonia Patients Undergoing Oral Glucocorticoid Treatment

References

• Alsayed AR, Al-Dulaimi A, Alkhatib M, et al. A comprehensive clinical guide for Pneumocystis jirovecii pneumonia: a missing therapeutic target in HIV-uninfected patients. Expert Rev Respir Med. 2022;1–24. doi:10.1080/17476348.2022.2152332
   PubMed Web of Science ®Google Scholar
• Tang G, Tong S, Yuan X, et al. Using routine laboratory markers and immunological indicators for predicting Pneumocystis jiroveci pneumonia in immunocompromised patients. Front Immunol. 2021;12:652383. doi:10.3389/fimmu.2021.652383
   PubMed Web of Science ®Google Scholar
• Roblot F, Le Moal G, Kauffmann-Lacroix C, et al. Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment. Scand J Infect Dis. 2014;46(3):210–214. doi:10.3109/00365548.2013.865142
   PubMed Web of Science ®Google Scholar
• Asai N, Motojima S, Ohkuni Y, et al. Clinical manifestations and prognostic factors of Pneumocystis jirovecii pneumonia without HIV. Chemotherapy. 2017;62(6):343–349. doi:10.1159/000477332
   PubMed Web of Science ®Google Scholar
• Weyant RB, Kabbani D, Doucette K, et al. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 2021;22(12):1579–1592. doi:10.1080/14656566.2021.1915989
   PubMed Web of Science ®Google Scholar
• Agustí C, Rañó A, Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response. Chest. 2003;123(2):488–498. doi:10.1378/chest.123.2.488
   PubMed Web of Science ®Google Scholar
• Kotani T, Katayama S, Miyazaki Y, et al. Risk factors for the mortality of pneumocystis jirovecii pneumonia in non-HIV patients who required mechanical ventilation: a retrospective case series study. Biomed Res Int. 2017;2017:7452604. doi:10.1155/2017/7452604
   PubMed Web of Science ®Google Scholar
• Cilloniz C, Dominedo C, Alvarez-Martinez MJ, et al. Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Rev Anti Infect Ther. 2019;17(10):787–801. doi:10.1080/14787210.2019.1671823
   PubMed Web of Science ®Google Scholar
• Liu CJ, Lee TF, Ruan SY, et al. Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients. Infect Drug Resist. 2019;12:1457–1467. doi:10.2147/IDR.S199761
   PubMed Web of Science ®Google Scholar
• Verhaert M, Blockmans D, De Langhe E, et al. Pneumocystis jirovecii pneumonia in patients treated for systemic autoimmune disorders: a retrospective analysis of patient characteristics and outcome. Scand J Rheumatol. 2020;49(5):345–352. doi:10.1080/03009742.2020.1762921
   PubMed Web of Science ®Google Scholar
• Carmona EM, Limper AH. Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis. 2011;5(1):41–59. doi:10.1177/1753465810380102
   PubMedGoogle Scholar
• Tasaka S, Kobayashi S, Yagi K, et al. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization. J Infect Chemother. 2014;20(11):678–681. doi:10.1016/j.jiac.2014.07.001
   PubMed Web of Science ®Google Scholar
• Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev. 2012;25(2):297–317. doi:10.1128/CMR.00013-12
   PubMed Web of Science ®Google Scholar
• Roux A, Canet E, Valade S, et al. Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis. 2014;20(9):1490–1497. doi:10.3201/eid2009.131668
   PubMed Web of Science ®Google Scholar
• Alvarez-Martinez MJ, Miro JM, Valls ME, et al. Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microbiol Infect Dis. 2006;56(2):153–160. doi:10.1016/j.diagmicrobio.2006.03.010
   PubMed Web of Science ®Google Scholar
• Connett GJ. Bronchoalveolar lavage. Paediatr Respir Rev. 2000;1(1):52–56. doi:10.1053/prrv.2000.0007
   PubMedGoogle Scholar
• Azoulay E, Roux A, Vincent F, et al. A multivariable prediction model for pneumocystis jirovecii pneumonia in hematology patients with acute respiratory failure. Am J Respir Crit Care Med. 2018;198(12):1519–1526. doi:10.1164/rccm.201712-2452OC
   PubMed Web of Science ®Google Scholar
• Feng Q, Hao J, Li A, et al. Nomograms for Death from Pneumocystis jirovecii Pneumonia in HIV-Uninfected and HIV-Infected Patients. Int J Gen Med. 2022;15:3055–3067. doi:10.2147/IJGM.S349786
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. doi:10.1164/rccm.200405-644ST
   PubMed Web of Science ®Google Scholar
• Ling J, Anderson T, Warren S, et al. Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients. Clin Kidney J. 2017;10(6):845–851. doi:10.1093/ckj/sfx044
   PubMed Web of Science ®Google Scholar
• Park JW, Curtis JR, Kim MJ, et al. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole. Arthritis Res Ther. 2019;21(1):207. doi:10.1186/s13075-019-1996-6
   PubMed Web of Science ®Google Scholar
• Park JW, Curtis JR, Moon J, et al. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2018;77(5):644–649. doi:10.1136/annrheumdis-2017-211796
   PubMed Web of Science ®Google Scholar
• Schmajuk G, Jafri K, Evans M, et al. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. Semin Arthritis Rheum. 2019;48(6):1087–1092. doi:10.1016/j.semarthrit.2018.10.018
   PubMed Web of Science ®Google Scholar
• Li Y, Ren L, Liu X, et al. Pulse corticosteroids in treatment of rheumatic disease concomitant with cytomegalovirus infection. Int J Rheum Dis. 2019;22(4):583–591. doi:10.1111/1756-185X.13467
   PubMed Web of Science ®Google Scholar
• Li L, Hsu SH, Gu X, et al. Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study. BMJ Open. 2020;10(10):e037419. doi:10.1136/bmjopen-2020-037419
   PubMed Web of Science ®Google Scholar
• Desmet S, Van Wijngaerden E, Maertens J, et al. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol. 2009;47(12):3871–3874. doi:10.1128/JCM.01756-09
   PubMed Web of Science ®Google Scholar
• Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest. 2007;131(4):1173–1180. doi:10.1378/chest.06-1467
   PubMed Web of Science ®Google Scholar
• Fishman JA, Gans H. Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13587. doi:10.1111/ctr.13587
   PubMedGoogle Scholar
• Steyerberg EW, Uno H, Ioannidis JPA, et al. Poor performance of clinical prediction models: the harm of commonly applied methods. J Clin Epidemiol. 2018;98:133–143. doi:10.1016/j.jclinepi.2017.11.013
   PubMed Web of Science ®Google Scholar
• Goeman JJ. L1 penalized estimation in the Cox proportional hazards model. Biom J. 2010;52(1):70–84. doi:10.1002/bimj.200900028
   PubMed Web of Science ®Google Scholar
• Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804. doi:10.1016/j.eururo.2018.08.038
   PubMed Web of Science ®Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19(6):716–723. doi:10.1109/TAC.1974.1100705
   Web of Science ®Google Scholar
• Liebling M, Rubio E, Ie S. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS? Expert Rev Respir Med. 2015;9(2):171–181. doi:10.1586/17476348.2015.1002471
   PubMed Web of Science ®Google Scholar
• Martin SI, Fishman JA. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):272–279. doi:10.1111/ajt.12119
   PubMed Web of Science ®Google Scholar
• Ghembaza A, Vautier M, Cacoub P, et al. Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases. Chest. 2020;158(6):2323–2332. doi:10.1016/j.chest.2020.05.558
   PubMed Web of Science ®Google Scholar
• Alanio A, Dellière S, Voicu S, et al. The presence of Pneumocystis jirovecii in critically ill patients with COVID-19. J Infect. 2021;82(4):84–123. doi:10.1016/j.jinf.2020.10.034
   PubMed Web of Science ®Google Scholar
• Alsayed AR, Talib W, Al-Dulaimi A, et al. The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan. Bosn J Basic Med Sci. 2022;22(5):784–790. doi:10.17305/bjbms.2022.7335
   PubMed Web of Science ®Google Scholar
• Kilic A, Elliott S, Hester L, et al. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples. J Mycol Med. 2020;30(2):100936. doi:10.1016/j.mycmed.2020.100936
   PubMed Web of Science ®Google Scholar
• Wan R, Bai L, Yan Y, et al. A clinically applicable nomogram for predicting the risk of invasive mechanical ventilation in Pneumocystis jirovecii pneumonia. Front Cell Infect Microbiol. 2022;12:850741. doi:10.3389/fcimb.2022.850741
   PubMed Web of Science ®Google Scholar
• Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487–2498. doi:10.1056/NEJMra032588
   PubMed Web of Science ®Google Scholar
• Bollée G, Sarfati C, Thiéry G, et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest. 2007;132(4):1305–1310. doi:10.1378/chest.07-0223
   PubMed Web of Science ®Google Scholar
• Crans CA, Boiselle PM. Imaging features of Pneumocystis carinii pneumonia. Crit Rev Diagn Imaging. 1999;40(4):251–284. doi:10.3109/10408379991249194
   PubMedGoogle Scholar
• Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71(1):5–13. doi:10.4065/71.1.5
   PubMed Web of Science ®Google Scholar
• Komano Y, Harigai M, Koike R, et al. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Rheum. 2009;61(3):305–312. doi:10.1002/art.24283
   PubMed Web of Science ®Google Scholar
• Roblot F, Godet C, Le Moal G, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2002;21(7):523–531. doi:10.1007/s10096-002-0758-5
   PubMed Web of Science ®Google Scholar
• Sepkowitz KA, Brown AE, Telzak EE, et al. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA. 1992;267(6):832–837. doi:10.1001/jama.1992.03480060078034
   PubMed Web of Science ®Google Scholar
• Mecoli CA, Saylor D, Gelber AC, et al. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience. Clin Exp Rheumatol. 2017;35(4):671–673.
   PubMed Web of Science ®Google Scholar